dc.contributor | Agudelo Berruecos, Yuli | |
dc.contributor | Vallejos, Alvaro | |
dc.creator | Santisteban Pérez, Natalia | |
dc.date.accessioned | 2013-08-05T21:35:15Z | |
dc.date.available | 2013-08-05T21:35:15Z | |
dc.date.created | 2013-08-05T21:35:15Z | |
dc.date.issued | 2013 | |
dc.identifier | http://repository.urosario.edu.co/handle/10336/4514 | |
dc.identifier | https://doi.org/10.48713/10336_4514 | |
dc.description.abstract | Introduction: Tuberculosis (TB) is considered a highly prevalent disease worldwide and a public health problem by the decrease in the cure rate since the appearance of multi-resistant TB and widespread, so it is necessary to design emerging management strategies to slow down the increasing incidence of TB worldwide. Methods: We performed a systematic literature research through PubMed and HINARI directing the search to studies evaluating outcomes of MDR TB management according to the goals set by last WHO guide. Results: We collected 9 articles tracking a cohort in different parts worldwide according to the inclusion criteria, in the sample collected from these 9 articles, 4720 people were treated from the beginning, 4163 (88%) of the cases were identified as MDR TB and 557 (12%) cases accounted for XDR TB. From this sample were excluded patients transferred to other institutions, leaving a total of 4455. We found that the overall cure rate exceeds 50% of the sample with individualized management however; mortality remains representative and higher compared with other variables. Conclusions: The studies evaluated multiple management strategies in different countries without conclusive results about a standardized management strategy. Elaborate a meta-analysis is not possible due to the poor characterization of the treatment schedules used in each study and poorly delineated definitions. | |
dc.language | spa | |
dc.publisher | Universidad del Rosario | |
dc.publisher | Toxicología Clínica | |
dc.publisher | Facultad de Medicina | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights | Abierto (Texto completo) | |
dc.rights | Atribución-NoComercial-SinDerivadas 2.5 Colombia | |
dc.rights | EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. | |
dc.source | Pontali E, Matteelli A, Migliori G. Drug-resistant tuberculosis. Curr Opin Pulm Med 2013; 19:266–272 | |
dc.source | Prasad R.M. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB) Management: Current Issues. Clinical Epidemiology and Global Health. 2013. IN PRESS. | |
dc.source | instname:Universidad del Rosario | |
dc.source | reponame:Repositorio Institucional EdocUR | |
dc.subject | Fallo terapéutico | |
dc.subject | Tuberculosis drogo resistente | |
dc.subject | Tuberculosis multiresistente | |
dc.subject | Tuberculosis de resistencia extendida | |
dc.subject | Terapéutica | |
dc.subject | Resultados del tratamiento | |
dc.title | Desenlaces del tratamiento de pacientes adultos con tuberculosis multiresistente y con resistencia extendida. Revisión sistemática. | |
dc.type | masterThesis | |